Add Yahoo as a preferred source to see more of our stories on Google. A new "proteomic" blood test can accurately screen a newborn's DNA for thousands of rare, inherited diseases by analyzing just a ...
The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.
A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days. A groundbreaking blood test promises to transform ...
Sanofi will take venglustat to regulators for Gaucher disease but an application for Fabry disease is less clear after the failure of a Phase III trial.
Both analyses come standard with every MyOme Rare Disease Test—at no additional burden to patients or providers. This advancement is made possible through MyOme's genome platform that includes ...
Hosted on MSN
New test can rapidly detect thousands of rare genetic diseases: ‘Revolutionary to families’
A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days and potentially eliminating the need for invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results